New ADHD drug studied in kids as young as 4
NCT ID NCT05721235
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 25 times
Summary
This study looked at how safe and tolerable the medication Azstarys is for children aged 4 and 5 with ADHD. About 123 children took the drug for up to 12 months, and researchers tracked any side effects. The goal was to see if this treatment is suitable for managing ADHD symptoms in this younger age group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AIM Trials
Plano, Texas, 75093, United States
-
Accel Research Sites - Lakeland
Lakeland, Florida, 33803, United States
-
Accel Research Sites - Maitland
Maitland, Florida, 32751, United States
-
Advanced Research Center (ARC)
Anaheim, California, 92805, United States
-
Alivation Research, LLC
Lincoln, Nebraska, 68526, United States
-
Boeson Research
Missoula, Montana, 59804, United States
-
CNS Healthcare - Orlando
Orlando, Florida, 32801, United States
-
CenExel iResearch, LLC
Savannah, Georgia, 31405, United States
-
Center For Psychiatry and Behavioral Medicine Inc
Las Vegas, Nevada, 89128, United States
-
Clinical Neuroscience Solution, Inc
Memphis, Tennessee, 38119, United States
-
Clinical Neuroscience Solutions - Orlando
Jacksonville, Florida, 32256, United States
-
DelRicht Research - Touro Medical Center
New Orleans, Louisiana, 70115, United States
-
Flourish Research
San Antonio, Texas, 78229, United States
-
Houston Clinical Trials
Bellaire, Texas, 77401, United States
-
IMMUNOe International Research Center
Centennial, Colorado, 80112, United States
-
Preferred Research Partners (PRP)
Little Rock, Arkansas, 72211, United States
-
Sky Clinical Research Network Group P.C.
Union City, Georgia, 30291, United States
-
South Florida Research Phase I-IV INC
Miami Springs, Florida, 33166, United States
-
St Charles Psychiatric Associates & Midwest Research Group
Saint Charles, Missouri, 63304, United States
-
iResearch Atlanta
Decatur, Georgia, 30030, United States
Conditions
Explore the condition pages connected to this study.